Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine.

Goadsby PJ, Wietecha LA, Dennehy EB, Kuca B, Case MG, Aurora SK, Gaul C.

Brain. 2019 Jul 1;142(7):1894-1904. doi: 10.1093/brain/awz134.

2.

Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study.

Kuca B, Silberstein SD, Wietecha L, Berg PH, Dozier G, Lipton RB; COL MIG-301 Study Group.

Neurology. 2018 Dec 11;91(24):e2222-e2232. doi: 10.1212/WNL.0000000000006641. Epub 2018 Nov 16.

3.

Results of a phase I study in patients suffering from secondary-progressive multiple sclerosis demonstrating the safety of the amino acid copolymer PI-2301 and a possible induction of an anti-inflammatory cytokine response.

Kovalchin J, Krieger J, Genova M, Collins K, Augustyniak M, Masci A, Hittinger T, Kuca B, Edan G, Braudeau C, Rimbert M, Patel U, Mascioli E, Zanelli E.

J Neuroimmunol. 2010 Aug 25;225(1-2):153-63. doi: 10.1016/j.jneuroim.2010.04.008. Epub 2010 May 13.

PMID:
20466440
4.

[Therapeutic results and changes in prognosis in patients with multiple myeloma in central and northern Moravia over the past 40 years].

Scudla V, Bacovský J, Indrák K, Kod'ousková V, Vytrasová M, Faber E, Papajík T, Vavrdová V, Adam Z, Hájek R, Farbiaková V, Srovnalík K, Novosadová L, Vránová M, Micaníková M, Sumná E, Kuca B, Slezar J, Heincová V, Gumulec J, Zivná J, Schlemmer P, Lautnerová E, Lasota Z, Kubecková M, Krajsová I, Růzicka M, Cíhal K, Martínek A, Cernosek B, Doubravský J, Papajík J, Prodĕlal P.

Vnitr Lek. 2002 Aug;48(8):707-17. Czech.

PMID:
12425200
5.

[Autologous transplantation of peripheral hematopoietic cells and subsequent maintenance therapy with interferon alpha or interferon alpha and dexamethasone in patients with multiple myeloma--results from the 4W randomized clinical trial of the Czech Myeloma Group].

Krejcí M, Hájek R, Scudla V, Bacovský J, Indrák K, Faber E, Koza V, Schützová M, Kuca B, Sumná E, Franková H, Lehanka F, Gumulec J, Stavarová Y, Rezek Z, Praskac P, Cahová S, Vránová M, Veprek K, Januska J, Kessler P, Pozdĕnová V, Walterová L, Stefánek I, Hausdorf P, Meluzínová I, Novosadová L, Lenícková S, Dusek L, Syobodník A, Králová E, Adam Z, Mayer J, Vorlícek J.

Vnitr Lek. 2001 Sep;47 Suppl 1:40-7. Czech.

PMID:
11693062
6.

[Treatment of multiple myeloma with high-dose chemotherapy and transplantation of autologous hematopoietic stem cells and subsequent maintenance therapy with interferon alfa-2b or interferon alfa 2b and dexamethasone. Report of the ongoing study of the "4W" Czech Myeloma Group].

Adam Z, Krejcí M, Bacovský J, Hejlová N, Kuca B, Svojgrová M, Franková H, Gumulec J, Janca J, Veprek K, Januska B, Lehanka F, Rezek Z, Praskac P, Cahová S, Vránová M, Papajík T, Králová E, Novotná J, Scudla V, Koza V, Drbal J, Faber E, Mareschová I, Hájek R, et al.

Vnitr Lek. 1998 Jul;44(7):400-8. Czech.

PMID:
9748876
7.

A phase I trial of recombinant human interleukin-11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy.

Gordon MS, McCaskill-Stevens WJ, Battiato LA, Loewy J, Loesch D, Breeden E, Hoffman R, Beach KJ, Kuca B, Kaye J, Sledge GW Jr.

Blood. 1996 May 1;87(9):3615-24.

PMID:
8611685
8.

A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy.

Tepler I, Elias L, Smith JW 2nd, Hussein M, Rosen G, Chang AY, Moore JO, Gordon MS, Kuca B, Beach KJ, Loewy JW, Garnick MB, Kaye JA.

Blood. 1996 May 1;87(9):3607-14.

PMID:
8611684
9.

Exercise intensity and glucose tolerance in trained and nontrained subjects.

Young JC, Enslin J, Kuca B.

J Appl Physiol (1985). 1989 Jul;67(1):39-43.

PMID:
2668256
10.

Effect of different incremental exercise protocols on the determination of lactate and ventilatory thresholds.

Ribeiro JP, Yang J, Adams RP, Kuca B, Knutten HG.

Braz J Med Biol Res. 1986;19(1):109-17.

PMID:
3801719
11.

[A 2-year echocardiographic study of patients with irreversible renal failure].

Rubácek M, Balabán D, Kuca B.

Vnitr Lek. 1984 Aug;30(8):771-6. Czech. No abstract available.

PMID:
6506499

Supplemental Content

Support Center